FGF ligands bind and activate cell surface FGF receptors (FGFR) to mediate multiple processes during embryogenesis. One ligand, FGF8, has been proposed to play divergent roles in LR patterning[@R5]-[@R9]; as a left determinant in mouse and a right determinant in chick and rabbit. Experimental manipulations of FGFR function allow cell-autonomous alterations of FGF signaling not possible with manipulations of multiple secreted ligands that activate a given receptor. Using this approach, we investigated the roles of FGFR1 in zebrafish development. To elucidate the role of FGFR1 signaling in LR development, we analyzed the expression of *southpaw* (*spaw*; zebrafish *nodal* homolog) the earliest known asymmetrically expressed gene[@R10]. Knockdown of FGFR1 with two distinct antisense morpholinos (MO) perturbed the normal left-sided expression of *spaw* in lateral plate mesoderm (LPM) ([Fig. 1a-c](#F1){ref-type="fig"}). Ets transcription factors *pea3* and *erm*, downstream targets of FGF signaling[@R11], were down-regulated in *fgfr1* morphants ([Supplemental Fig. 1](#SD1){ref-type="supplementary-material"}), indicating the efficacy of MO knockdown. Markers of notochord (*no tail, lefty1, sonic hedgehog*)[@R12], [@R13] and floorplate (*sonic hedgehog*), were found to be normal in *fgfr1* morphants ([Supplemental Fig. 2](#SD1){ref-type="supplementary-material"}), suggesting the barrier role of the embryonic midline is intact. These results indicate FGFR1 signaling is required early in LR development, preceding asymmetric expression of *spaw*.

*spaw* asymmetry is dependent on Kupffer's vesicle (KV), a ciliated epithelium structure that creates directional fluid flow[@R12]-[@R14], analogous to 'nodal flow' in mouse[@R15]. *Fgfr1* mRNA is expressed in KV and surrounding tailbud ([Fig. 1d, e](#F1){ref-type="fig"}). To determine whether FGF signaling functions cell-autonomously in KV cells to control *spaw* asymmetry, we generated chimeric DFC^*fgfr1*\ MO^ embryos in which *fgfr1* is knocked-down in DFC/KV (dorsal forerunner cells; KV precursor cells) lineages[@R12] but not the rest of the embryo. Similar to embryo-wide knockdown of *fgfr1*, DFC^*fgfr1*\ MO^ embryos had significant alterations in *spaw* expression relative to DFC^Control\ MO^ (p\<1.19e-05; [Fig. 1c, f-h](#F1){ref-type="fig"}). As an important control, the effects of knockdown of FGFR1 in yolk alone (yolk^*fgfr1*\ MO^) were similar to yolk^control\ MO^ ([Fig. 1h](#F1){ref-type="fig"}; p\<0.90). These results indicate that cell-autonomous FGFR1 signaling in DFC/KV cells is necessary for asymmetric expression of *spaw* in LPM.

What role does FGFR1 signaling play in DFC/KV function? Atypical Protein Kinase C (aPKC), an apical marker of polarized KV epithelial cells[@R16], revealed that KV were of normal size and shape in *fgfr1* morphants ([Fig. 2a, b](#F2){ref-type="fig"}; n=15/15, control n=16/16), in contrast to dismorphic KV phenotypes seen in *ntl* or *spt* mutants and morphants[@R16]. Thus, morphogenesis of the KV epithelium is not dependent on FGFR1 signaling. However, KV cilia were shorter in *fgfr1* MO-1 compared to Control morphants and WT embryos ([Fig. 2a-c](#F2){ref-type="fig"}; p\<1.9e-08); the number of cilia was unaltered ([Fig. 2](#F2){ref-type="fig"}; p\<0.98). Similar results were obtained from *fgfr1* MO-2 (data not shown). Importantly, *Xenopus fgfr1* mRNA[@R17] rescued cilia defects induced by *fgfr1* MO ([Fig. 2c](#F2){ref-type="fig"}, p\<4.70e-05), demonstrating that cilia defects in *fgfr1* morphants are specific to FGFR1 knockdown.

Additional approaches were used to assess the requirement of FGFR signaling for normal KV cilia length. Embryos treated during shield stage with a pharmacological inhibitor of FGFR activity, SU5402[@R18], [@R19], had shorter cilia compared to DMSO-treated controls ([Fig. 2d](#F2){ref-type="fig"}; p\<3.26e-06). Treatment at subsequent stages altered LR development but not cilia length (JMN & HJY, in prep), suggesting FGF signaling plays multiple stage-specific roles in LR development. We analyzed transgenic embryos carrying a heat-shock inducible dominant negative FGFR1 (DN-FGFR) fused to eGFP which identifies transgenic embryos from their non-transgenic siblings[@R20]. When DN-FGFR was activated at 60% epiboly, transgenic embryos had shorter cilia compared to heat-shocked non-transgenic siblings ([Fig. 2e](#F2){ref-type="fig"}; p\<6.94e-03) and non-heat-shocked siblings ([Fig. 2e](#F2){ref-type="fig"}; p\<6.99e-03), both of which had normal length cilia ([Fig. 2e](#F2){ref-type="fig"}; p\<0.61). Brief hyperactivation of FGF signaling by inducible FGFR[@R21] avoided overexpression defects but did not increase cilia length ([Supplemental Fig 3](#SD1){ref-type="supplementary-material"}).

Which ligands signal through FGFR1 to control cilia length? FGF8 binds several FGFRs[@R22] and FGFR1 morphants phenocopy midbrain-hindbrain defects seen in zebrafish FGF8 (*acerebellar*; *ace*) mutants[@R5], [@R23]. This suggests FGFR1 is a functional receptor for FGF8[@R23]. *ace* mutants have LR defects and a minority fail to form a KV lumen[@R5]. We found *fgf8* deficient embryos express KV differentiation markers (*sox17*, n=87/98), form an epithelium with normal apical-basal polarity (aPKC, n=10/10), and despite 33% not filling the KV lumen, develop normal numbers of cilia with normal length ([Fig. 2f](#F2){ref-type="fig"}; p\<0.53).

Another FGF ligand, *fgf24*, has overlapping expression with *fgf8* in and around DFC/KV cells[@R24]. *fgf24* mutants (*ikarus*; *ika*)[@R25] and siblings had normal length KV cilia (average cilia length=6.2 μm; 498 cilia; 12 embryos). To test for redundant function of FGF8 and FGF24, we injected *fgf24* MO into *ace* mutants to reduce the amount of FGF8/FGF24 activity. *ace* heterozygotes injected with *fgf24* MO had shorter KV cilia than uninjected *ace* heterozygotes ([Fig. 2f](#F2){ref-type="fig"}; p\<0.015), and *ace* homozygotes injected with *fgf24* MO had KV cilia lengths comparable to *fgfr1* morphants ([Fig.2f](#F2){ref-type="fig"}; p\<3.63e-07). Similarly, *ika* mutants injected with *fgf8* MO had shorter cilia ([Supplemental Figure 4](#SD1){ref-type="supplementary-material"}). WT, *ika* mutants and siblings injected with *fgf24* MO had normal length cilia ([Fig. 2f](#F2){ref-type="fig"}; p\<0.28), arguing against off-target MO effects. These results indicate that FGF8 and FGF24 ligands function, likely through FGFR1, to control cilia length. Thus, results from MO against FGFR1, pharmacological inhibitors of FGFRs, transgenic expression of DN-FGFR, and mutants and MO of multiple FGF ligands indicate that FGF signaling is necessary to control KV cilia length.

To assess whether cilia-driven directional fluid flow in KV was altered by the cilia defects in *fgfr1* morphants, we tracked movement of fluorescent beads injected into the lumen of KV[@R13]. In control morphants, fluorescent beads exhibited a persistent counter-clockwise directional flow ([Fig. 2i](#F2){ref-type="fig"}, Supplemental Movie 1). In contrast, beads in *fgfr1* morphants had no persistent directional flow ([Fig. 2j](#F2){ref-type="fig"}, Supplemental Movie 2) indicating FGF signaling controls LR patterning by regulating cilia length and KV fluid flow prior to initiation of asymmetric *spaw* expression.

The discovery that FGF signaling plays a role in LR patterning by regulating cilia suggests other developmental roles attributed to FGF signaling might be due to cilia defects. To determine whether FGF-dependent regulation of cilia length is a more general developmental mechanism, we examined cilia in two epithelia that express FGFR1, the pronephric ducts and ear (otic vesicle; [Supplemental Fig. 5b, c](#SD1){ref-type="supplementary-material"}). Pronephric ducts are primitive excretory organs containing motile cilia[@R14]. Inhibition of FGF signaling during *Xenopus* embryogenesis inhibits pronephric development[@R26], but no mechanism has been elucidated. Pronephric duct cilia at 26 somite stage (SS) were shorter in *fgfr1* morphants compared to WT embryos ([Fig. 3a, b, e](#F3){ref-type="fig"}; p\<4.24e-04). Consistent with pronephric cilia defects, *fgfr1* morphants develop cystic kidneys ([Supplemental Fig. 6](#SD1){ref-type="supplementary-material"}). In the zebrafish ear, two types of cilia are required for otolith formation: tethering cilia and motile cilia. Tethering cilia attract seeding granules and when reduced in number or length, granules are not organized correctly for otolith formation[@R19]. In zebrafish FGF8 or FGFR1 knock-down perturbs otic vesicle and otolith formation[@R23], and otic vesicle cilia number is altered when FGF signaling is pharmacologically inhibited[@R18]. Here, *fgfr1* morphants had shorter tethering cilia and otolith defects ([Fig. 3c-d, d](#F3){ref-type="fig"}, [Supplementary Fig. 6d-e](#SD1){ref-type="supplementary-material"}; p\< 1.1e-07), suggesting the otic vesicle and otolith defects seen in *fgfr1* MO are due to defects in cilia length. Thus FGF signaling controls cilia length and function in multiple tissues during zebrafish development.

To explore whether control of cilia length by FGF signaling is conserved in vertebrates, two types of epithelial cilia were examined in *Xenopus laevis*: monocilia on gastrocoel roof plate (GRP) implicated in LR patterning[@R4], and mucociliary epithelial cilia that move fluid across the external epidermis[@R3]. Since DN-FGFR causes gastrulation defects when expressed ubiquitously during early embryogenesis, we co-injected DN-FGFR and GFP mRNA into cell lineages that contribute to either the GRP or mucociliary epithelium ([Supplemental Fig. 1d-f](#SD1){ref-type="supplementary-material"}). GRP cells co-expressing GFP and DN-FGFR had shorter cilia compared to neighboring GRP cells in the same embryo (p\<6.0e-03; [Fig. 3i-j, m](#F3){ref-type="fig"}) and GRP cells in embryos expressing GFP alone (p\<2.7e-03; [Fig. 3g-h, m](#F3){ref-type="fig"}). In mucociliary epithelial, cells co-expressing GFP and DN-FGFR had shorter cilia compared to cells expressing GFP alone (p\<0.019; [Fig. 3k-i, n](#F3){ref-type="fig"}). These results indicate that FGF signaling controls cilia length in diverse epithelia, and suggests that the regulation of cilia length by FGF signaling is evolutionarily conserved.

How does FGFR1 regulate cilia length? To address this, we analyzed cell differentiation, epithelial cell polarization and cilia formation of KV cells in zebrafish[@R16]. In *fgfr1* morphants, two markers of the DFC/KV cell lineage, sox17[@R12] and *dnah9*[@R13], showed similar expression in WT and *fgfr1* morphants, indicating correct DFC/KV cell differentiation ([Fig. 4a-d, i](#F4){ref-type="fig"}). Apical membrane marker aPKC and tight junction marker ZO-1 revealed apical-basal polarity in KV cells was intact in *fgfr1* morphants compared to WT controls ([Supplemental Fig. 7a-d](#SD1){ref-type="supplementary-material"}). Further, cilia in *fgfr1* morphants were correctly positioned at the apical surface facing the KV lumen ([Supplemental Fig. 7e, f](#SD1){ref-type="supplementary-material"}). In contrast to the apparent normal differentiation and polarization of KV cells in *fgfr1* morphants, two members of transcription factor families implicated in ciliogenesis[@R27], [@R28], *foxJ1* and *rfx2* (BWB and HJY, in preparation) were down-regulated in these embryos ([Fig. 4e, f, i](#F4){ref-type="fig"}). Correspondingly, expression of *polaris*, an intraflagellar transport gene (Ift88) required for normal length cilia in zebrafish[@R29], was diminished in *fgfr1* morphants ([Fig. 4g-i](#F4){ref-type="fig"}). Reduced *polaris* expression is consistent with IFT-defective phenotypes seen in *fgfr1* morphants, including curved body axis, kidney cysts and shortened cilia ([Fig. 2a-f](#F2){ref-type="fig"}, [Supplemental Fig. 6](#SD1){ref-type="supplementary-material"}). From these results, we propose that FGF8 and FGF24 activate FGFR1 cell-autonomously in KV cells to maintain a transcriptional network that allows normal expression of IFT proteins required for normal length cilia ([Fig. 4j](#F4){ref-type="fig"}).

Monocilia are found on almost all cells and have been implicated as sites for receiving or modulating cell-cell signaling pathways such as Hedgehog[@R1], PDGF[@R1] and Wnt[@R2]. Interactions among signaling pathways are of great interest in understanding how cells integrate diverse signals. Extrapolating from our discovery of a link between FGF signaling and cilia function in zebrafish and *Xenopus*, we propose that (1) some of the apparent interactions between FGF signaling and other cell signaling pathways might be due to FGF-dependent changes in cilia, which then influence the ability of cells to receive and integrate other cell-cell signals, and (2) a spectrum of developmental defects and human diseases due to defects in FGF signaling might be due to defects in cilia length or function.

Methods Summary {#S1}
===============

*Xenopus* mRNA Injections {#S2}
-------------------------

For *Xenopus* GRP monocilia analysis, embryos were injected with 200 pg GFP mRNA alone (lineage tracer) or co-injected with 400 pg DN-FGFR mRNA into two dorsal cells of 32-cell embryo. For *Xenopus* epithelial cell analysis, embryos were injected with 200 pg GFP mRNA alone or co-injected with 600 pg dnFGFR mRNA into a single ventral cell of a 16-cell embryo.

Statistics {#S3}
----------

Cilia measurements were analyzed using a two-tailed student's T-test, and analysis of *spaw* proportions were conducted using Fisher's exact test. In a given embryo each cilium was measured in the tissue of interest and the average cilia length per embryo was determined. Averages for controls and experimentals were compared within each clutch of embryos. Outcomes were the same using a second analytical approach in which all cilia lengths were pooled and compared across all series of experiments. Analysis was done by R-Commander software package within the R Statistical Software platform[@R30]. Results are considered significant when p\< 0.05 and results are expressed as mean±standard error of the mean.
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Methods {#S5}
=======

Zebrafish and *Xenopus* embryo culture {#S6}
--------------------------------------

Oregon AB WT zebrafish (*Danio rerio*) were collected from natural matings, and were injected, raised and staged as described previously[@R13]. Heterozygote crosses with *ace^ti282a^*, *fgf24^t22030^*, and hsp70:dn-fgfr1were used to produce *ace* and *fgf24* mutant embryos and hsp:dn-fgfr1 transgenic embryos respectively[@R5], [@R20], [@R23], [@R25]. Hsp70:dnfgfr1 embryos from heterozygote crosses were incubated at 28°C (no heat-shock activation) or at 60% epiboly for one hour at 37 °C (heat-shock activation) and then returned to 28°C until collected for IHC. *Xenopus* embryos were obtained using standard methods as previously described[@R3].

Morpholino and mRNA injections {#S7}
------------------------------

Antisense morpholino oligonucleotides (MO) were obtained from Gene Tools, LLC and Open Biosystems. Fluorescently labeled MOs against FGFR1 were designed using previously described sequences: translation blocking 3-carboxyfluorescein-labeled *fgfr1* MO-1 (5′- GCAGCAGCGTGGTCTTCATTATCAT-3′)[@R23], [@R31], translation blocking 3-carboxyfluorescein-labeled *fgfr1* MO-2 (5′-CAAAGATCCTCTACATCTGAACTCC-3′)[@R31]. The *fgf24* MO (5′-AGGAGACTCCCGTACCGTACTTGCC-3′) and the 3-lissamine-labeled fgf8 MO (5′-TAGGATGCTCTTACCATGAACGTCG-3′) have also been previously described[@R24], [@R32]. Fluorescein-labeled standard negative control (5′-CCTCTTACCTCAGTTACAATTTATA-3′) from Gene Tools, LLC was used in control injections. MO was injected into 1-4 cell zebrafish embryos for whole embryo protein knock-down experiments [@R13]. A volume of 1 nl was delivered containing 5 ng of *fgf24* MO, 4 ng of *fgfr1* MO-1, 8 ng of *fgfr1* MO-2, or 4 ng of Control MO. For DFC^MO^ experiments, fluorescent MO was injected into the yolk of embryos at 500-1000 cell stage and embryos were selected by fluorescent microscopy for MO accumulation in DFC as previously described[@R12]. To control for activity of the protein of interest in the yolk alone we used yolk^MO^ control injections: fluorescent MO was injected into dome-30% epiboly embryos, and embryos were selected by fluorescent microscopy for MO diffusion throughout the yolk. For DFC^MO^ and yolk^MO^ injections 1 nl was delivered containing 2 ng of *fgfr1* MO-1 or 2 ng of Control MO. Capped xFGFR1, DN-FGFR, iFGFR[@R21] and GFP mRNAs were made from linearized plasmid using the using the mMessage machine SP6 transcription kit (Ambion)[@R17]. For MO rescue experiments, 100 pg of xFGFR1 was injected alone or co-injected with 5 ng of *fgfr1* MO-1 into 1-4 cell stage zebrafish embryos. For iFGFR experiments, 2.5 pg of iFGFR was injected into 1-4 cell stage zebrafish embryos.

In Situ Hybridization {#S8}
---------------------

Digoxigenin RNA probes were generated using a Roche DIG RNA labeling kit. cDNA templates used include *spaw*[@R10], *shh*[@R13], *ntl*[@R12], *fgfr1*[@R23], *sox17*[@R12], *pea3*[@R11], *erm*[@R11], *lefty1*[@R13], *dnah9*[@R13], *polaris*[@R29], *foxJ1* (BWB unpublished), *rfx2* (BWB unpublished). In situ hybridization were performed as previously described[@R13], with automated wash and antibody incubation using a Biolane HTI machine (Huller and Huttner HG). After post-fixation, embryos were cleared in 100% EtOH for imaging. Embryos were stored in 70% glycerol and images were obtained and processed using a Nikon Coolpix5000 camera and Photoshop Software (Adobe).

Immunofluorescence Microscopy {#S9}
-----------------------------

For zebrafish immunohistochemistry, embryos were fixed in 4% paraformaldehyde at 4°C, dehydrated in a MeOH series, stored in 100% MeOH, rehydrated, boiled in 1 mM EDTA for five minutes (except IHC for pronephric cilia), and subsequently blocked for 1 hour in PBS containing 5% sheep serum, 1% BSA, 1% DMSO, and 0.1% Triton-X. Embryos were incubated in primary antibody including mouse anti- acetylated Tubulin (1:300, Sigma T-6793), rabbit anti-atypical Protein Kinase C ζ (1:100; Santa Cruz sc-216), and mouse anti-ZO-1 (1:150; Zymed 33-9100). After washes with PBS/0.1% Triton-X/1% DMSO/1% BSA embryos were blocked for 1 hour and incubated in secondary antibody, including goat anti-rabbit Alexa Fluor 647 and goat anti-mouse Alexa Fluor 488. Embryos were cleared and mounted in Slow Fade Reagent (Molecular Probes). Images were acquired using an Olympus Fluoview FV300 laser scanning confocal microscope and assembled using ImageJ (NIH) and Photoshop (Adobe) software. Confocal z-series images were assembled to present the sum of the focal planes; cilia length was measured using Metamorph software (Universal Imaging Corp). For GRP monocilia imaging, injected *Xenopus* embryos were collected at stage 17[@R33], the vitelline membrane removed, fixed overnight in 4% PFA in PBS, dehydrated in methanol and stored at -20C. Embryos were dissected following rehydration to expose GRP cilia according previous methods[@R4]. For epithelial cilia analysis, injected embryos were collected at stage 26 and kept whole[@R3]. Embryos were blocked in 10% lamb serum in PBS/0.1% Triton-X (PBST), with PBST only washes. Cilia were labeled as for zebrafish and injected cells were visualized using a polyclonal GFP antibody (1:400; Torrey Pines Biolabs). Anti-mouse Alexa fluor 568 and anti-rabbit Alexa fluor 488 secondary antibodies were used. Samples were mounted in PBST and imaged using an Olympus Fluoview FV300 confocal microscope. To measure epithelial cilia length, images were processed using Fluoview software to render the cilia in the x-z plane and then images and cilia length for both epithelial and GRP cilia were measured as for zebrafish.

KV Flow Analysis {#S10}
----------------

Embryos were dechorionated at 6-8 SS and mounted in 1% low melt agarose. Fluorescent beads (0.5-2 μm; Polysciences, Inc.) were injected into KV and imaged on a Leica DMRA compound microscope using a 40x Plan Apo objective using a Coolsnap HQ digital camera (Photometrics), Metamorph (Universal Imaging Corp) to track individual beads and calculate velocity and Quicktime (Apple) to display movies.

Pharmacological Treatments {#S11}
--------------------------

Shield-stage embryos were incubated in 24 well tissue culture dishes (25-30 embryos per well) in either SU5402 (Calbiochem)[@R18], [@R19] resuspended in DMSO or AP20187 (Ariad) resuspended in EtOH, diluted into embryo water to a concentration of 20-25μM for SU5402 (concentration dependant on drug lot) or 1.25 μM for AP20187. For a vehicle control, an equivalent volume of DMSO or EtOH was added to embryo water. At after 1 hour, embryos were washed with embryo water and incubated in the 24 well dishes until fixed for IHC.

![Cell autonomous FGF signaling in Kupffer's Vesicle controls Left-Right patterning\
(a-b) Dorsal view of left-sided *spaw* expression (arrow) in WT, and bilateral expression in *fgfr1* MO 18-20 SS embryos. (c) Percentages of normal (left-sided), reversed, bilateral and absent *spaw* in WT (n=99), *fgfr1* MO (n=117) and *fgfr1* MO2 (n=120). (d-e) *fgfr1* expression in WT 6 SS embryos. (d) Lateral view (anterior-left) showing *fgfr1* expression in KV (bracket) and midbrain-hindbrain (red arrowhead). (e) Tailbud showing *fgfr1* expression in KV (white arrow, dorsal view), presomitic mesoderm (red arrowhead) and lateral plate mesoderm (black arrow). (f-g) *spaw* expression (arrows) in DFC^Control\ MO^ and DFC^*fgfr1*\ MO^ at 18-20 SS. (h) Percentages of *spaw* expression in DFC and Yolk MO injected embryos. *spaw* was altered in DFC^*fgfr1*\ MO^ (n=69) versus DFC^Control\ MO^ (p\<1.19e-05; n=121), with no difference between Yolk^Control\ MO^ (n= 57) and Yolk ^*fgfr1*\ MO^ (p\<0.90; n= 59).](nihms-102692-f0001){#F1}

![FGF signaling controls cilia length and directional fluid flow in Kupffer's Vesicle\
(a-b) Confocal images of 10 SS embryos, KV labeled with antibodies against aPKC (red) and acetylated tubulin (green). Control and *fgfr1* morphants had similar KV structure, but cilia were shorter in *fgfr1* morphants (compare insets in a and b). (c) Cilia lengths were significantly different (p\< 2.88e-06) in *fgfr1* morphants (688 cilia; 18 embryos) versus Control morphants (437 cilia; 9 embryos). Cilia length was similar in WT uninjected (533 cilia; 10 embryos) and Control morphant (p\< 0.93), cilia numbers per KV were similar in Control and *fgfr1* morphants (p\< 0.26). Cilia length defects in *fgfr1* morphants were rescued by *Xenopus* FGFR1 (xFGFR1) mRNA (p\< 4.70e-05; 807 cilia; 21 embryos). Injection of xFGFR1 mRNA alone had no affect on cilia length (p\<0.73; 526 cilia, 14 embryos). (d) Embryos treated with SU5402 during shield stage (248 cilia; 12 embryos) had shorter cilia compared to DMSO control embryos (p\<3.26e-06; 686 cilia; 15 embryos). (e) Cilia were shorter in transgenic DN-FGFR embryos that were heat shocked at 60% epiboly (656 cilia; 19 embryos) compared to heat shocked non-transgenic siblings (p\<6.94e-03; 375 cilia; 10 embryos) and non-heat-shocked siblings (p\<6.99e-03; 910 cilia; 16 embryos). (f) There was no difference in cilia length (p\<0.28) in *fgf24* morphants (455 cilia; 10 embryos) versus Control morphants (481 cilia; 10 embryos). However, cilia were shorter when both FGF8 and FGF24 ligands were diminished (*fgf24* MO in *ace* mutants; 12 embryos; 244 cilia), compared to single ligand knockdown (FGF8/*ace* mutants: p\< 1.39e-04; 10 embryos; 480 cilia; *fgf24* MO in *ace* sibs: p\< 3.44e-04; 15 embryos; 643 cilia) and WT *ace* siblings (p\<3.63e-07; 13 embryos; 626 cilia). (g-h) DIC images of bead-injected KVs in Control and *fgfr1* morphants injected with fluorescent beads. (i-j) Bead paths tracked by Metamorph software. Directional KV fluid flow was absent in *fgfr1* morphants (j; p\< 6.4e-15; 44 beads, 9 embryos) compared to counterclockwise flow in Control morphants (i; 39 beads, 8 embryos). Error bars are standard error of the mean (s.e.m).](nihms-102692-f0002){#F2}

![Cilia length in pronephric ducts, otic vesicles, gastrocoel roof plate epithelia and mucociliary epithelia is controlled by FGF signaling\
(a-b) Pronephric duct cilia were shorter and disorganized in *fgfr1* morphants (p\<4.24×10^-4^; 528 cilia; 10 embryos,) compared to WT (517 cilia; 10 embryos) 26 SS embryos. (c-d) Otic vesicle tethering cilia (arrows, and inset) were shorter (p\< 1.10e-07) in *fgfr1* morphants (325 cilia; 10 embryos) compared to WT embryos (322 cilia; 8 embryos) at 24 hpf. (g-j, m). GRP cilia in *Xenopus* embryos were normal length in cells expressing GFP alone (green cells in g, outlined in h; 316 cilia 18 embryos, p\<0.11), neighboring cells (outside boundaries in h; 653, 18 embryos), and cells neighboring DN-FGFR+GFP expression (outside boundaries in j; 652 cilia 15 embryos, p\<0.99). In contrast, GRP cilia were shorter in cells expressing DN-FGFR+GFP (i, inside boundaries in j; 155 cilia, 15 embryos) compared to neighboring cells (p\<6.1e-03) and cells expressing GFP alone (p\<2.7e-03). (k, l) Z plane rendering of mucociliary epithelia (scale bar 20 um), showing shorter cilia in cells expressing DN-FGFR+GFP (13 cells, 7 embryos) compared to controls expressing GFP alone (14 cells, 4 embryos). (n) Multicilia area is reduced in cells expressing DN-FGFR+GFP (p\<0.019). Error bars are s.e.m.](nihms-102692-f0003){#F3}

![FGF signaling controls ciliogenic genes in DFC/KV cells\
(a, b) *sox17* expression in DFC/KV (and endoderm cells in a different focal plane) in 90% epiboly embryos was normal in *fgfr1* morphants and WT embryos. (c, d) Expression of *dnah9* in 95 % epiboly embryos was normal in *fgfr1* morphants and WT embryos. (e, f) In contrast, *foxJ1* was down-regulated in *fgfr1* morphants versus WT embryos at 90% epiboly. (g, h) Similarly, *polaris* was down-regulated in *fgfr1* morphants versus WT embryos at tailbud stage. (i) Comparison of percentage of embryos with WT expression levels of each gene indicated. (j) Proposed mechanism by which FGF signaling controls length of motile cilia: FGF ligands bind to FGFR1 activating downstream transcription factors (TF) including *foxj1* and *rfx2*, these TF activate IFT genes (e.g. *polaris*) to maintain motile cilia length on epithelial cells.](nihms-102692-f0004){#F4}
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